Literature DB >> 18511345

Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells.

M M Suhoski1, E E Perez, M L Heltzer, A Laney, L G Shaffer, S Saitta, S Nachman, N B Spinner, C H June, J S Orange.   

Abstract

Monosomy 1p36 is a subtelomeric deletion syndrome associated with congenital anomalies presumably due to haploinsufficiency of multiple genes. Although immunodeficiency has not been reported, genes encoding costimulatory molecules of the TNF receptor superfamily (TNFRSF) are within 1p36 and may be affected. In one patient with monosomy 1p36, comparative genome hybridization and fluorescence in- situ hybridization confirmed that TNFRSF member OX40 was included within the subtelomeric deletion. T cells from this patient had decreased OX40 expression after stimulation. Specific, ex vivo T cell activation through OX40 revealed enhanced proliferation, and reduced viability of patient CD4+ T cells, providing evidence for the association of monosomy 1p36 with reduced OX40 expression, and decreased OX40-induced T cell survival. These results support a role for OX40 in human immunity, and calls attention to the potential for haploinsufficiency deletions of TNFRSF costimulatory molecules in monosomy 1p36.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511345      PMCID: PMC2583253          DOI: 10.1016/j.clim.2008.03.522

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

1.  Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome.

Authors:  Heidi A Heilstedt; Blake C Ballif; Leslie A Howard; Richard A Lewis; Samuel Stal; Catherine D Kashork; Carlos A Bacino; Stuart K Shapira; Lisa G Shaffer
Journal:  Am J Hum Genet       Date:  2003-04-08       Impact factor: 11.025

Review 2.  A co-evolution perspective of the TNFSF and TNFRSF families in the immune system.

Authors:  Yves Collette; André Gilles; Pierre Pontarotti; Daniel Olive
Journal:  Trends Immunol       Date:  2003-07       Impact factor: 16.687

3.  Monosomy 1p36 breakpoint junctions suggest pre-meiotic breakage-fusion-bridge cycles are involved in generating terminal deletions.

Authors:  Blake C Ballif; Wei Yu; Chad A Shaw; Catherine D Kashork; Lisa G Shaffer
Journal:  Hum Mol Genet       Date:  2003-07-15       Impact factor: 6.150

4.  A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes.

Authors:  Anna K Thomas; Marcela V Maus; Waleed S Shalaby; Carl H June; James L Riley
Journal:  Clin Immunol       Date:  2002-12       Impact factor: 3.969

5.  Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

Authors:  Marcela V Maus; Anna K Thomas; Debra G B Leonard; David Allman; Kathakali Addya; Katia Schlienger; James L Riley; Carl H June
Journal:  Nat Biotechnol       Date:  2002-02       Impact factor: 54.908

6.  The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion.

Authors:  I Gramaglia; A Jember; S D Pippig; A D Weinberg; N Killeen; M Croft
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

Review 7.  OX-40: life beyond the effector T cell stage.

Authors:  A D Weinberg; A T Vella; M Croft
Journal:  Semin Immunol       Date:  1998-12       Impact factor: 11.130

Review 8.  Costimulation of T cells by OX40, 4-1BB, and CD27.

Authors:  Michael Croft
Journal:  Cytokine Growth Factor Rev       Date:  2003 Jun-Aug       Impact factor: 7.638

9.  Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo.

Authors:  Phyllis-Jean Linton; Beverly Bautista; Elana Biederman; Evan S Bradley; Judith Harbertson; Robyn M Kondrack; Ryan C Padrick; Linda M Bradley
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

10.  OX40 (CD134) controls memory T helper 2 cells that drive lung inflammation.

Authors:  Shahram Salek-Ardakani; Jianxun Song; Beth S Halteman; Amha Gebre-Hiwot Jember; Hisaya Akiba; Hideo Yagita; Michael Croft
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

View more
  1 in total

1.  Do microdeletions lead to immune deficiency?

Authors:  Sait Karaman; Filiz Hazan; Semiha Bahçeci Erdem; Nesrin Gülez; Ferah Genel
Journal:  Cent Eur J Immunol       Date:  2020       Impact factor: 2.085

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.